AEON icon

AEON Biopharma

21 hedge funds and large institutions have $20.5M invested in AEON Biopharma in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 13 reducing their positions, and 69 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
21
Holders Change
-64
Holders Change %
-75.29%
% of All Funds
0.34%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
5
Increased
2
Reduced
13
Closed
69
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
LA
76
Linden Advisors
New York
-$375K -518 Closed
ACA
77
Arena Capital Advisors
California
-$308K -425 Closed
E
78
Ergoteles
New York
-$262K -363 Closed
AGC
79
Angelo Gordon & Co
New York
-$251K -347 Closed
CCM
80
Cinctive Capital Management
New York
-$251K -347 Closed
TI
81
Tidal Investments
Wisconsin
-$248K -342 Closed
RCM
82
Robinson Capital Management
Michigan
-$248K -342 Closed
KKRC
83
Kohlberg Kravis Roberts & Co
New York
-$223K -308 Closed
LCM
84
Landscape Capital Management
New Jersey
-$207K -287 Closed
TAM
85
Terrapin Asset Management
Florida
-$201K -278 Closed
AA
86
Ancora Advisors
Ohio
-$169K -233 Closed
FC
87
Foursixthree Capital
New York
-$101K -139 Closed
6CM
88
683 Capital Management
New York
-$101K -139 Closed
BlackRock
89
BlackRock
New York
-$101K -139 Closed
UBS Group
90
UBS Group
Switzerland
-$8.06K -11 Closed